Improving Care for Marginalized Populations at Risk for Hereditary Cancer Syndromes: Innovations that Expanded Reach in the CHARM Study

Affiliations

• ¹ Department of Translational and Applied Genomics, Kaiser Permanente Center for Health Research, Portland, Oregon, USA, marian.j.gilmore@kpchr.org.
• ² Department of Health Systems and Population Health, School of Public Health, University of Washington, Seattle, Washington, USA.
• ³ Treuman Katz Center for Pediatric Bioethics and Palliative Care, Seattle Children's Research Institute, Seattle, Washington, USA.
• ⁴ Department of Translational and Applied Genomics, Kaiser Permanente Center for Health Research, Portland, Oregon, USA.
• ⁵ RTI International, Washington, District of Columbia, USA.
• ⁶ Institute for Health Research, Kaiser Permanente, Aurora, Colorado, USA.
• ⁷ Genomics, Ethics, and Translational Research Program, RTI International, Research Triangle Park, North Carolina, USA.
• ⁸ Division of Ethics, Department of Medical Humanities and Ethics, Columbia University, New York, New York, USA.
• ⁹ Kaiser Permanente Center for Health Research, Portland, Oregon, USA.
• ¹⁰ Department of Medicine (Medical Genetics), University of Washington Medical Center, Seattle, Washington, USA.
• ¹¹ Genome Medical, South San Francisco, California, USA.
• ¹² Ambulatory Care Services, Denver Health, Denver, Colorado, USA.
• ¹³ The Comparative Health Outcomes, Policy and Economics (CHOICE) Institute, School of Pharmacy, University of Washington, Seattle, Washington, USA.
• ¹⁴ Department of Humanities and Social Sciences, University of California, San Francisco, California, USA.